Your browser doesn't support javascript.
loading
TCR-induced FOXP3 expression by CD8+ T cells impairs their anti-tumor activity.
Lozano, Teresa; Conde, Enrique; Martín-Otal, Celia; Navarro, Flor; Lasarte-Cia, Aritz; Nasrallah, Rabab; Alignani, Diego; Gorraiz, Marta; Sarobe, Pablo; Romero, Juan P; Vilas, Amaia; Roychoudhuri, Rahul; Hervás-Stubbs, Sandra; Casares, Noelia; Lasarte, Juan José.
Afiliación
  • Lozano T; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain. Electronic address: tlmoreda@unav.es.
  • Conde E; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Martín-Otal C; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Navarro F; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Lasarte-Cia A; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Nasrallah R; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, UK.
  • Alignani D; Flow Cytometry Core, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Gorraiz M; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Sarobe P; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Romero JP; Oncohematology Programs, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Vilas A; Oncohematology Programs, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Roychoudhuri R; Laboratory of Lymphocyte Signalling and Development, Babraham Institute, Cambridge, UK; Division of Immunology, Department of Pathology, University of Cambridge, Cambridge, UK.
  • Hervás-Stubbs S; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Casares N; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain.
  • Lasarte JJ; Immunology and Immunotherapy, Center for Applied Medical Research (CIMA), University of Navarra, 31008, IdISNA, Pamplona, Spain. Electronic address: jjlasarte@unav.es.
Cancer Lett ; 528: 45-58, 2022 03 01.
Article en En | MEDLINE | ID: mdl-34973390
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Inmunoterapia Adoptiva / Linfocitos T CD8-positivos / Factores de Transcripción Forkhead Límite: Animals / Humans Idioma: En Revista: Cancer Lett Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Receptores de Antígenos de Linfocitos T / Inmunoterapia Adoptiva / Linfocitos T CD8-positivos / Factores de Transcripción Forkhead Límite: Animals / Humans Idioma: En Revista: Cancer Lett Año: 2022 Tipo del documento: Article Pais de publicación: Irlanda